Investigating the shared genetic architecture between multiple sclerosis and inflammatory bowel diseases
An epidemiological association between multiple sclerosis (MS) and inflammatory bowel disease (IBD) is well-established, but a genetic link is unclear. Here, the authors investigate the shared genetic architecture between MS and IBD to shed light on the biological basis of comorbidity.
Main Authors: | Yuanhao Yang, Hannah Musco, Steve Simpson-Yap, Zhihong Zhu, Ying Wang, Xin Lin, Jiawei Zhang, Bruce Taylor, Jacob Gratten, Yuan Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-09-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-021-25768-0 |
Similar Items
-
Helminth therapy – local and systemic activity, on example of inflammatory bowel diseases and multiple sclerosis
by: Marta Maruszewska-Cheruiyot, et al.
Published: (2019-12-01) -
Health-related outcomes and economic burden in Japan: focus on inflammatory bowel disease, multiple sclerosis, and depression
by: Yamabe K
Published: (2018-10-01) -
Infliximab in inflammatory bowel disease
by: Konstantinos Papamichael, et al.
Published: (2019-03-01) -
Pulmonary Manifestations of Inflammatory Bowel Disease
by: Jacob Gelberg, et al.
Published: (2013-01-01) -
The Bowel Microbiota and Inflammatory Bowel Diseases
by: Gerald W. Tannock
Published: (2010-01-01)